Flavia Foca

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori

Italy

Research Interests

Explore related searches

Professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (4)

Nicola Gentili

IRCCS Istituto Romagnolo per lo Studio dei Tumori Dino Amadori

ITALY

View details

Alberto Russi

Istituto Oncologico Veneto Istituto di Ricovero e Cura a Carattere Scientifico

ITALY

View details

Alberto Bongiovanni

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori

ITALY

View details

Chiara Liverani

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Flavia Foca

Research Interests

Explore related searches

Contact this professor

Articles (10)

Healthcare Costs and Resource Utilisation of Italian Metastatic Non-Small Cell Lung Cancer Patients

Real-World Safety and Outcome of First-Line Pembrolizumab Monotherapy for Metastatic NSCLC with PDL-1 Expression ≥ 50%: A National Italian Multicentric Cohort (“<i>PEMBROREAL</i>” Study)

Radiotherapy at the End of Life: From Retrospective Analysis to Strategies to Improve Outcomes

Systemic Inflammatory Indices in Second-Line Soft Tissue Sarcoma Patients: Focus on Lymphocyte/Monocyte Ratio and Trabectedin

Association between Pre-Treatment Biological Indicators and Compliance to Neoadjuvant/Perioperative Chemotherapy in Operable Gastric Cancer

Malignant Pleural Mesothelioma: Preliminary Toxicity Results of Adjuvant Radiotherapy Hypofractionation in a Prospective Trial (MESO-RT)

Real-World Outcomes and Treatments Patterns Prior and after the Introduction of First-Line Immunotherapy for the Treatment of Metastatic Non-Small Cell Lung Cancer

Prognostic and Predictive Role of Body Composition in Metastatic Neuroendocrine Tumor Patients Treated with Everolimus: A Real-World Data Analysis.

<sup>177</sup>Lu-DOTATATE Efficacy and Safety in Functioning Neuroendocrine Tumors: A Joint Analysis of Phase II Prospective Clinical Trials

Long-term vemurafenib therapy in advanced melanoma patients: cutaneous toxicity and prognostic implications

Collaborators (4)

Nicola Gentili

Alberto Russi

Alberto Bongiovanni

Chiara Liverani

Make your next move.